Mechanisms of acquisition of vanA operon among vancomycin-resistant Staphylococcus aureus genomes: the tip of the iceberg?

Tram Vo,Pierre Pontarotti,Jean-Marc Rolain,Vicky Merhej
DOI: https://doi.org/10.1016/j.ijantimicag.2024.107154
IF: 15.441
2024-04-10
International Journal of Antimicrobial Agents
Abstract:Vancomycin is frequently used as a last line defence against infections due to multidrug resistant Staphylococcus aureus . A recent finding described the acquisition of vancomycin-resistant S. aureus (VRSA) strains by the integration of an enterococcal plasmid containing vanA operon into the chromosome of S. aureus via homologous recombination (HR) involving a specific integration site called locus L2. To characterise all mechanisms of acquisition of vanA, we analysed the 15,706 genomes of S. aureus looking for vanA and described its genetic environment. We found a complete vanA operon in 25 S. aureus strains isolated from twelve patients, including nine being co-isolated with VRE strains. VanA was found within transposon Tn1546-like elements, on seventeen plasmids and eight chromosomes. VanA might be acquired through conjugation of enterococcal and staphylococcal plasmids, transposition of Tn1546 carrying vanA and plasmid integration into the chromosome. We detected L2 in 2,087 genomes (13.3%) of S. aureus strains across different continents and identified six potential chromosomal hotspots for integration of the entire vanA -containing enterococcal plasmid by HR via L2. This suggests that the scenario recently described in the New York patient could be reproduced anywhere. Surveillance of this possibility is mandatory, especially in patients with VRSA and VRE infection or colonisation.
pharmacology & pharmacy,infectious diseases,microbiology
What problem does this paper attempt to address?